Endece hopes to collect enough data so the U.S. Food and Drug Administration will accelerate clinical testing enough to have the drug on the market in five to seven years.
http://www.biztimes.com/article/2012043 ... -CURING-MS
Endece hopes to collect enough data so the U.S. Food and Drug Administration will accelerate clinical testing enough to have the drug on the market in five to seven years.
Great point, LainieLainie wrote:I welcome any new drug that could be effective. It's not their fault that the author who wrote the headline is an idiot.
cheerIf a drug could be developed that would actually repair the formation of myelin, I believe it would be used in combination with those anti-inflammatory therapies. It would not compete. It would be an add-on that would expand the number of treatment options currently available for MS patients."
Not all patients are eligible to receive anti-inflammatory treatments, Trapp said. But all MS patients would qualify for a myelin repair therapy, he said.